The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; none of the 6 sources its claims cite is checked for support yet.
SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin
Open accessAbstract
The Sir2 deacetylase regulates chromatin silencing and lifespan in Saccharomyces cerevisiae. In mice, deficiency for the Sir2 family member SIRT6 leads to a shortened lifespan and a premature ageing-like phenotype. However, the molecular mechanisms of SIRT6 function are unclear. SIRT6 is a chromatin-associated protein, but no enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown. Here we show that the human SIRT6 protein is an NAD+-dependent, histone H3 lysine 9 (H3K9) deacetylase that modulates telomeric chromatin. SIRT6 associates specifically with telomeres, and SIRT6 depletion leads to telomere dysfunction with end-to-end chromosomal fusions and premature cellular senescence. Moreover, SIRT6-depleted cells exhibit abnormal telomere structures that resemble defects observed in Werner syndrome, a premature ageing disorder. At telomeric chromatin, SIRT6 deacetylates H3K9 and is required for the stable association of WRN, the factor that is mutated in Werner syndrome. We propose that SIRT6 contributes to the propagation of a specialized chromatin state at mammalian telomeres, which in turn is required for proper telomere metabolism and function. Our findings constitute the first identification of a physiological enzymatic activity of SIRT6, and link chromatin regulation by SIRT6 to telomere maintenance and a human premature ageing syndrome.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Human SIRT6 is an NAD+-dependent histone H3 lysine 9 (H3K9) deacetylase that associates with telomeres in S phase and maintains low H3K9 acetylation there. SIRT6 depletion causes telomere dysfunction, chromosomal end-to-end fusions, and premature cellular senescence, and impairs WRN association at telomeric chromatin, linking SIRT6 to telomere maintenance and Werner syndrome-like defects.
Key findings
- SIRT6 knockdown in WI-38 human fibroblasts shortened replicative lifespan, causing premature senescence about ten population doublings before controls, with increased senescence-associated β-galactosidase staining; two independent SIRT6 shRNAs reproduced this, while irrelevant shRNAs did not.
- SIRT6-depleted cells showed elevated telomere dysfunction-induced foci, non-recurrent chromosomal end-to-end fusions that were more pronounced at later population doublings, and Werner syndrome-like telomere abnormalities including sister telomere loss, telomere doublets, and weak or absent telomere signals at fusion sites; mean telomere length was not significantly reduced.
- SIRT6 deacetylated H3K9Ac specifically among tested acetylated histone peptides, with no deacetylation detected for 12 other acetylated histone peptides; the catalytic mutant H133Y markedly decreased activity. SIRT6 knockdown caused H3K9 hyperacetylation at telomeric chromatin in S phase, and S6KO mouse cells also showed telomeric H3K9 hyperacetylation.
- SIRT6 was required for stable WRN association at telomeric chromatin; SIRT6 knockdown significantly inhibited WRN association in U2OS and IMR90 cells. Telomerase expression reversed premature senescence, whereas augmenting base excision repair did not, and low oxygen culture did not prevent senescence.
Methods
- Retrovirus-mediated shRNA knockdown of SIRT6 in WI-38, IMR90, U2OS, and HeLa cells, with replicative senescence assays, SA-β-gal staining, immuno-FISH TIF assays, metaphase cytogenetics/SKY/telomere FISH, and cell-cycle flow cytometry.
- Telomere chromatin immunoprecipitation (T-ChIP) after thymidine synchronization and release, using antibodies against SIRT6, Flag, WRN, and H3K9Ac, with telomeric DNA detected by slot blot.
- In vitro histone deacetylation assays with recombinant SIRT6 and acetylated histone tail peptides or full-length histones, including mass spectrometry; 293T cells were transfected with wild-type or H133Y SIRT6 and analyzed by Western blotting.
Limitations
- Stated: SIRT6 showed only modest in vitro deacetylation activity on H3K9Ac peptides, and no direct SIRT6-WRN interaction at chromatin was observed, although additional functional or physical interactions might exist.
- Stated: S6KO mouse cells showed telomeric H3K9 hyperacetylation but did not display the downstream cellular defects seen in human cells, which the authors attribute to the large functional reserve of mouse telomeres.
- Evident: many conclusions rely on shRNA knockdown and overexpression in cultured cells, and several supporting results are reported as “data not shown”; global H3K9Ac levels did not differ significantly, so the key effect is telomere-specific.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
29 Own result · 23 Own interpretation · 3 Not checked yet · 1 Own method · 1 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As controls, the association of Alu repeat sequences with SIRT6 ChIPs was not above background (Fig. 2b–d), and the SIRT6 T-ChIP signal was abolished in S6KD cells, validating the specificity of the signal (Fig. 2d).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In both U2OS and IMR90 cells, SIRT6 knockdown significantly inhibited the association of WRN with telomeric chromatin (Fig. 4a, b, and data not shown).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, mean telomere length was not significantly reduced in S6KD cells (Supplementary Fig. 5).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Inactivation of SIRT6 leads to H3K9 hyperacetylation at telomeric chromatin in both human and mouse cells, but the mouse cells do not display the downstream cellular defects observed in human cells, which is consistent with the large functional reserve of mouse telomeres (Supplementary Fig. 13d; data not shown)14,25.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, telomere stabilization (by the ectopic expression of telomerase (hTERT)) reversed the premature senescence of S6KD, whereas augmenting BER (by the ectopic expression of the DNA polymerase-β dRP lyase domain) did not (Fig. 1g and Supplementary Fig. 6).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Inactivation of SIRT6 leads to H3K9 hyperacetylation at telomeric chromatin in both human and mouse cells, but the mouse cells do not display the downstream cellular defects observed in human cells, which is consistent with the large functional reserve of mouse telomeres (Supplementary Fig. 13d; data not shown)14,25.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, telomere stabilization (by the ectopic expression of telomerase (hTERT)) reversed the premature senescence of S6KD, whereas augmenting BER (by the ectopic expression of the DNA polymerase-β dRP lyase domain) did not (Fig. 1g and Supplementary Fig. 6).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Analysis of TIFs revealed elevated telomere dysfunction in S6KD cells (Fig. 1d, e, and Supplementary Fig. 4a).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similarly, SIRT6 knockdown in U2OS cells resulted in delayed completion of S phase (Supplementary Fig. 14), which is consistent with a role for SIRT6 in modulating telomeres during replication.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, investigation of histone acetylation status at telomeres in S-phase-enriched cultures by T-ChIP revealed H3K9 hyperacetylation in S6KD cells (Fig. 3d–f).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 18
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Premature cellular senescence was also observed with two independent SIRT6 shRNAs, ruling out off-target shRNA effects, but not with irrelevant shRNAs (Supplementary Fig 2b–d and Supplementary Fig 3c).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 occupancy at telomeric chromatin was observed for both recombinant Flag-tagged SIRT6 (Fig. 2a, b) and endogenous SIRT6 (Fig. 2c, d), and in both U2OS osteosarcoma cells (Fig. 2b, c) and primary IMR90 cells (Fig. 2d).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This activity was highly specific for H3K9Ac, because no deacetylation was detected for 12 other acetylated histone peptides (Fig. 3a and Supplementary Fig. 11).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 also deacetylated H3K9Ac, but not several other acetylated residues, in the context of purified full-length histone H3, and mutation of a conserved catalytic residue (H133Y) of SIRT6 markedly decreased this activity (Fig. 3b and data not shown).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 knockdown (S6KD) cells have a strikingly shortened replicative lifespan, undergoing premature cellular senescence about ten population doublings before control cells, and show increased levels of senescence-associated β-galactosidase (SA-β-gal) staining (Fig. 1b, c, and Supplementary Fig. 2a).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, SIRT6 efficiently and specifically deacetylated H3K9Ac (but not other acetylated histone residues) in 293T cells, whereas the mutant SIRT6 protein did not (Fig. 3c and Supplementary Fig. 12).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Non-recurrent chromosomal end-to-end fusions were observed in S6KD cells and were more pronounced at later population doublings, but they were rarely observed in control cells (Fig. 1f and Supplementary Fig. 4b, c).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, S6KD metaphases showed elevated levels of missing telomere signals (sister telomere loss) and extra telomere signals (telomere doublets) (Fig. 4d–f), defects observed in WS cells and associated with aberrant telomere processing during replication8,13,20.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these observations suggest that S6KD cells undergo accelerated senescence and telomere dysfunction in response to stochastic telomere sequence loss, without increased global telomere erosion.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We conclude that SIRT6 is crucial in maintaining a normal replicative life-span and in preventing the premature senescence of human cells.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these data locate SIRT6 at telomeric chromatin in S phase and suggest a potential role for SIRT6 in regulating replication-associated dynamics in telomere structure.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings suggest that SIRT6 collaborates with WRN at telomeric chromatin to ensure efficient telomere replication and to prevent the accrual of structural abnormalities at telomeres.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study has identified a crucial function for SIRT6 in chromatin regulation at mammalian telomeres and provides a new mechanism by which the regulation of chromatin is linked to telomere function, cellular senescence and, potentially, organismal ageing.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these observations indicate that SIRT6 is an NAD-dependent deacetylase with specificity for H3K9Ac.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose a model (Supplementary Fig. 1) in which the deacetylation of H3K9Ac by SIRT6 promotes the formation of a specialized telomeric chromatin state that is required for the stable association of S-phase-dependent telomere-processing factors such as WRN, to prevent aberrant sequence loss or metabolism of telomeres.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings demonstrate that telomere dysfunction, not BER defects or oxidative stress, underlie the premature senescence phenotype of S6KD cells.”
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose that SIRT6 contributes to the propagation of a specialized chromatin state at mammalian telomeres, which in turn is required for proper telomere metabolism and function.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our findings constitute the first identification of a physiological enzymatic activity of SIRT6, and link chromatin regulation by SIRT6 to telomere maintenance and a human premature ageing syndrome.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
No enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown.
“SIRT6 is a chromatin-associated protein3, but no enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown.”
“Although no physiological enzymatic activity for SIRT6 on histones or other trans substrate has yet been observed, we proposed that SIRT6 might regulate chromatin at telomeres by deacetylating a specific histone tail residue.”
The paper relies on this without support.
No effect of SIRT6 deficiency on cellular lifespan has been reported.
“Despite the ageing-like phenotype of SIRT6-deficient mice, no effect of SIRT6 deficiency on cellular lifespan has been reported.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“SIRT6 promotes DNA double strand break repair19,20, regulates telomere stability21, suppresses inflammation22 and opposes tumorigenesis23,24.”
From SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age (2014) · cites this paper as [21]
In the citing paper
“In human cells, loss of SIRT6, an H3K9 deacetylase that silences telomeres, causes telomere dysfunction and premature cellular senescence (Michishita et al., 2008).”
From The Aging Epigenome (2016) · cites this paper as Michishita et al., 2008
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Multicolor Spectral Karyotyping of Human Chromosomes
Schröck, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M. A., Ning, Y., Ledbetter, D. H., Bar‐Am, I., Soenksen, D. G., et al. (1996) · Science · doi:10.1126/science.273.5274.494 · Cited by 1,753
Self-citationTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6
Mostoslavsky, R., Chua, K. F., Lombard, D. B., Pang, W. W., Fischer, M. R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M. M., et al. (2006) · Cell · doi:10.1016/j.cell.2005.11.044 · Cited by 1,637
Self-citationDNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409
Michishita, E., Park, J. Y., Burneskis, J. M., Barrett, J. C., & Horikawa, I. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0033 · Cited by 1,364
Self-citationHerbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344
Cited by
Sorted by citations
Items 601–700 of 998
Age-related changes of human serum Sirtuin6 in adults
Zhao, Y., Bai, X., Jia, X., Lu, Y., Cheng, W., Shu, M., Zhu, Y., Zhu, L., Wang, L., Yan, S., et al. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02399-0 · Cited by 28
Sirtuins, a key regulator of ageing and age-related neurodegenerative diseases
Bhatt, V., & Tiwari, A. K. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2057849 · Cited by 28
Epigenetics and senescence: Learning from the INK4-ARF locus
Simboeck, E., Ribeiro, J. D., Teichmann, S., & Croce, L. D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.084 · Cited by 28
Sirt6 deficiency impairs corneal epithelial wound healing
Hu, X., Zhu, S., Liu, R., Miller, J. D., Merkley, K. H., Tilton, R. G., & Liu, H. (2018) · Aging · doi:10.18632/aging.101513 · Cited by 28
Metabolic modulation of chromatin: implications for DNA repair and genomic integrity
Liu, J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00182 · Cited by 26
Regulation of Cancer and Cancer-Related Genes via NAD +
Sharif, T., Martell, E., Dai, C., Ghassemi-Rad, M. S., Kennedy, B. E., Lee, P. W. K., & Gujar, S. A. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7478 · Cited by 25
SIRT6 Through the Brain Evolution, Development, and Aging
García-Venzor, A., & Toiber, D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.747989 · Cited by 28
Tsai, Y., Chen, S.-L., Peng, S.-L., Tsai, Y.-L., Chang, Z.-M., Chang, V. H.-S., & Ch’ang, H.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00687-8 · Cited by 27
Self-citationSo, K.-Y., Park, B., & Oh, S. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09528-2 · Cited by 25
Regulatory Effects of Statins on SIRT1 and Other Sirtuins in Cardiovascular Diseases
Khayatan, D., Razavi, S. M., Arab, Z. N., Khanahmadi, M., Momtaz, S., Butler, A. E., Montecucco, F., Markina, Y. V., Abdolghaffari, A. H., & Sahebkar, A. (2022) · Life · doi:10.3390/life12050760 · Cited by 25
Mormone, E., Iorio, E. L., Abate, L., & Rodolfo, C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1073689 · Cited by 31
Posttranslational control of telomere maintenance and the telomere damage response
Peuscher, M. H., & Jacobs, J. J. L. (2012) · Cell Cycle · doi:10.4161/cc.19847 · Cited by 27
TelAP1 links telomere complexes with developmental expression site silencing in African trypanosomes
Reis, H., Schwebs, M., Dietz, S., Janzen, C. J., & Butter, F. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky028 · Cited by 25
SIRT6 facilitates directional telomere movement upon oxidative damage
Gao, Y. D., Tan, J. J., Jin, J., Ma, H., Chen, X., Leger, B. S., Xu, J., Spagnol, S. T., Dahl, K. N., Levine, A. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23602-0 · Cited by 25
Giorgio, E. D., Dalla, E., Tolotto, V., D’Este, F., Paluvai, H., Ranzino, L., & Brancolini, C. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae501 · Cited by 26
Interplay Between the Circadian Clock and Sirtuins
Zhuang, Y., Zhang, Y., Liu, C., & Zhong, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111469 · Cited by 25
The Role of Increased Expression of Sirtuin 6 in the Prevention of Premature Aging Pathomechanisms
Dzidek, A., Czerwińska‐Ledwig, O., Żychowska, M., Pilch, W., & Piotrowska, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119655 · Cited by 24
Stem cells and aging: a chicken-or-the-egg issue?
Smith, J. A., & Daniel, R. (2012) · Europe PMC (PubMed Central) · Cited by 23
Endisha, H., Merrill, J. C., Zhao, M., Bristol, M. L., Wang, X., Kubben, N., & Elmore, L. W. (2015) · Pathobiology · doi:10.1159/000368856 · Cited by 22
The sirtuins in the pathogenesis of cancer
Voelter‐Mahlknecht, S., & Mahlknecht, U. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0008-0 · Cited by 24
Wirth, M., Karaca, S., Wenzel, D., Ho, L., Tishkoff, D. X., Lombard, D. B., Verdin, E. M., Urlaub, H., Jedrusik, M. A., & Fischle, W. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.02.002 · Cited by 22
Autophagy Regulating Kinases As Potential Therapeutic Targets For Age-Related Macular Degeneration
Kaarniranta, K., Kauppinen, A., Błasiak, J., & Salminen, A. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.169 · Cited by 23
Greenall, A., Lei, G., Swan, D. C., James, K., Wang, L., Peters, H., Wipat, A., Wilkinson, D. J., & Lydall, D. (2008) · Genome Biology · doi:10.1186/gb-2008-9-10-r146 · Cited by 23
LINE-1 transposable element renaissance in aging and age-related diseases
Li, X., Yu, H., Li, D., & Liu, N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102440 · Cited by 23
Metabolites as signalling molecules in the tumour immune microenvironment
Mao, Y., Xia, W., & Jiang, P. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-025-01258-y · Cited by 30
Overexpression of SIRT6 attenuates the tumorigenicity of hepatocellular carcinoma cells
Wang, Y., Pan, T., Wang, H., Li, L., Li, J., Zhang, D., & Yang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.19297 · Cited by 23
Structural Insight into the Interactions between Structurally Similar Inhibitors and SIRT6
Zhao, S., Zhu, Y., Wang, X., Liu, Y., Sun, Y., Zhao, Q., & Li, H.-Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072601 · Cited by 23
Dong, Z., Yang, C., Tan, J., Dou, C., & Chen, Y. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.024 · Cited by 23
Exploring the Multi-Faceted Role of Sirtuins in Glioblastoma Pathogenesis and Targeting Options
Kunadis, E., & Piperi, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112889 · Cited by 23
Zhang, M., Liu, W., Liu, Y., Zhang, Z., Hu, Y., Sun, D., Li, S., & Fang, J. (2023) · DNA and Cell Biology · doi:10.1089/dna.2023.0102 · Cited by 23
Expression and function of SIRT6 in muscle invasive urothelial carcinoma of the bladder.
Wu, M., Dickinson, S. I., Wang, X. B., & Zhang, J. (2014) · PubMed Central · Cited by 23
Identification of Novel Interacting Partners of Sirtuin6
Polyakova, O., Borman, S., Grimley, R. L., Vamathevan, J. J., Hayes, B. J., & Solari, R. C. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051555 · Cited by 23
Sirt6 alters adult hippocampal neurogenesis
Okun, E., Marton, D., Cohen, D., Griffioen, K. J. S., Kanfi, Y., Illouz, T., Madar, R., & Cohen, H. Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179681 · Cited by 23
Muraki, K., & Murnane, J. P. (2017) · Genes & Genetic Systems · doi:10.1266/ggs.17-00014 · Cited by 25
Combating cellular senescence by sirtuins: Implications for atherosclerosis
Ma, S., Fan, L., & Cao, F. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.011 · Cited by 23
Wirth, M., Paap, F., Fischle, W., Wenzel, D., Agafonov, D. E., Samatov, T. R., Wiśniewski, J. R., & Jedrusik, M. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00018-09 · Cited by 23
Telomeres do the (un)twist: Helicase actions at chromosome termini
Chavez, A., Tsou, A. M., & Johnson, F. B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.008 · Cited by 24
Histone Acetylation and Deacetylation
Fass, D. M., Kemp, M. M., Schroeder, F. A., Wagner, F. F., Wang, Q., & Holson, E. B. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201100036 · Cited by 23
Aging and Cancer: Are Sirtuins the Link?
Rodríguez, R. M. A., & Fraga, M. F. (2010) · Future Oncology · doi:10.2217/fon.10.57 · Cited by 22
Zheng, W., Tasselli, L., Li, T., & Chua, K. F. (2021) · Genes · doi:10.3390/genes12091460 · Cited by 22
Self-citationYuan, S., Liao, G., Zhang, M., Zhu, Y., Xiao, W., Wang, K., Li, C., Jia, C., Sun, N., Walch, A. K., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00337-3 · Cited by 21
SIRT6 : A potential therapeutic target for diabetic cardiomyopathy
Wu, T., Qu, Y., Xu, S., Wang, Y., Liu, X., & Ma, D. (2023) · The FASEB Journal · doi:10.1096/fj.202301012r · Cited by 23
SIRT6 promotes metastasis and relapse in HER2-positive breast cancer
Andreani, C., Bartolacci, C., Persico, G., Casciaro, F., Amatori, S., Fanelli, M., Giorgio, M., Galiè, M., Tomassoni, D., Wang, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-49199-7 · Cited by 23
Freitas, M., Rodrigues, A. R., Tomada, N., Fonseca, J., Magalhães, A. L., Gouveia, A., & Neves, D. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.13035 · Cited by 20
Non-Coding RNA Molecules Connect Calorie Restriction and Lifespan
Abraham, K. J., Ostrowski, L., & Mekhail, K. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.020 · Cited by 21
SIRT6 overexpression induces apoptosis of nasopharyngeal carcinoma by inhibiting NF-κB signaling
Ouyang, L., Liang, Y., Li, J., Yi, S., Li, S., Liu, P., & Yang, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s179866 · Cited by 21
RetractedShen, X., Chen, X., Huang, J., Xu, R., Cheng, J., & Jiang, H. (2020) · Journal of Molecular Histology · doi:10.1007/s10735-020-09857-w · Cited by 21
Nitro-fatty acids as activators of hSIRT6 deacetylase activity
Carreño, M., Bresque, M., Machado, M. R., Santos, L., Durán, R., Vitturi, D. A., Escande, C., & Denicola, A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014883 · Cited by 20
Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus
Méndez, C. (2015) · World Journal of Virology · doi:10.5501/wjv.v4.i3.219 · Cited by 23
González-Vasconcellos, I., Schneider, R., Anastasov, N., Alonso-Rodríguez, S., Sanli-Bonazzi, B., Fernández, J. L., & Atkinson, M. J. (2017) · Scientific Reports · doi:10.1038/srep42056 · Cited by 23
Sirtuin activators as an anti-aging intervention for longevity
Sah, P., Rai, A. K., & Syiem, D. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.100881 · Cited by 21
Gui, L., Raza, S. H. A., Garcia, M., Sun, Y., Ullah, I., & Han, Y.-C. (2018) · BMC Genomics · doi:10.1186/s12864-018-5149-0 · Cited by 20
Greenwald, S. H., Brown, E. E., Scandura, M. J., Hennessey, E., Farmer, R., Du, J., Wang, Y., & Pierce, E. A. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab070 · Cited by 20
Sirtuin 6 Protects Against Oxidative Stress and Vascular Dysfunction in Mice
Greiten, L. E., Zhang, B., Roos, C. M., Hagler, M. A., Jahns, F., & Miller, J. D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.753501 · Cited by 19
Multifaced role of protein deacetylase sirtuins in neurodegenerative disease
Gupta, R. V., Ambasta, R. K., & Kumar, P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.047 · Cited by 20
Georgieva, A. M., Guo, X., Bartkuhn, M., Günther, S., Künne, C., Smolka, C., Atzberger, A., Gärtner, U., Mamchaoui, K., Bober, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31798-z · Cited by 20
Liu, H., Wang, S., Gong, L., Shen, Y., Xu, F., Wang, Y., Hu, L., & Zhu, L. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.80920 · Cited by 22
Age-by-disease biological interactions: implications for late-life depression
McKinney, B. C., Oh, H., & Sibille, E. L. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00237 · Cited by 20
The sirtuin 6: An overture in skin cancer
Garcia‐Peterson, L. M., Guzmán‐Pérez, G., Krier, C. R., & Ahmad, N. (2019) · Experimental Dermatology · doi:10.1111/exd.14057 · Cited by 21
Bresque, M., Cal, K., Pérez-Torrado, V., Colman, L., Rodriguez‐Duarte, J., Vilaseca, C., Santos, L., Garat, M. P., Ruiz, S., Evans, F., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101711 · Cited by 21
Madsen, A. S., & Olsen, C. A. (2012) · Angewandte Chemie · doi:10.1002/ange.201203754 · Cited by 20
Paul, S., Kim, S. J., Park, H., Lee, S. Y., An, Y. R., Oh, M.-J., Jung, J. W., Ryu, J., & Hwang, S. Y. (2011) · Molecular & Cellular Toxicology · doi:10.1007/s13273-011-0032-y · Cited by 19
MSIT: Malonylation Sites Identification Tree
Bao, W., Huang, D.-S., & Chen, Y. (2020) · Current Bioinformatics · doi:10.2174/1574893614666190730110747 · Cited by 19
Xu, J., Shi, S., Liu, G., Xie, X., Li, J., Bolinger, A. A., Chen, H., Zhang, W., Shi, P., Liu, H., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114998 · Cited by 19
Xu, X., Zhang, Q., Wang, X., Jin, J., Wu, C., Li, F., Yang, X., Zhao, M., Chen, Y., Lu, S., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.014 · Cited by 19
RNA quality control factors nucleate Clr4/SUV39H and trigger constitutive heterochromatin assembly
Khanduja, J. S., Joh, R. I., Perez, M. M., Paulo, J. A., Palmieri, C. M., Zhang, J., Gulka, A. O. D., Haas, W., Gygi, S. P., & Motamedi, M. (2024) · Cell · doi:10.1016/j.cell.2024.04.042 · Cited by 20
Epigenetic Regulation of Telomere Chromatin Integrity in Pluripotent Embryonic Stem Cells
Wong, L. H. (2010) · Epigenomics · doi:10.2217/epi.10.49 · Cited by 23
Xia, W., & Geng, K. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.07.020 · Cited by 19
Li, Y., Li, X., Cole, A. P., McLaughlin, S. L., & Du, W. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1426413 · Cited by 20
Tang, C., Liu, P., Zhou, Y., Jiang, B., Song, Y., & Sheng, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28500 · Cited by 18
Screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cells
Tenhunen, J., Kučera, T., Huovinen, M., Küblbeck, J., Bisenieks, E., Vı̄gante, B., Ogle, Z., Duburs, G., Doležal, M., Moaddel, R., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111452 · Cited by 19
20-Hydroxyecdysone inhibits inflammation via SIRT6-mediated NF-κB signaling in endothelial cells
Jin, Z., Wang, B., Ren, L., Yang, J., Zheng, Z., Yao, F., Ding, R., Wang, J., He, J., Wang, W., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119460 · Cited by 18
Histone lysine modifying enzymes and their critical roles in DNA double-strand break repair
Zhang, J., Lu, X., MoghaddamKohi, S., Shi, L., Xu, X., & Zhu, W. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103206 · Cited by 18
SIRT6’s function in controlling the metabolism of lipids and glucose in diabetic nephropathy
Wang, Y., Liu, T., Cai, Y., Liu, W., & Guo, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1244705 · Cited by 19
The Role and Application of the AMPK-Sirtuins Network in Cellular Senescence
Han, Y.-K., Liu, Y., Zhang, Y., Wang, W., Lv, T., Huang, J., & Peng, X. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810250 · Cited by 20
A sirtuin link between metabolism and heart disease
Webster, K. A. (2012) · Nature Medicine · doi:10.1038/nm.2983 · Cited by 18
hnRNPA2 mediated acetylation reduces telomere length in response to mitochondrial dysfunction
Guha, M., Srinivasan, S., Johnson, F. B., Ruthel, G. T., Guja, K. E., García–Díaz, M., Kaufman, B. A., Glineburg, M. R., Fang, J.-K., Nakagawa, H., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206897 · Cited by 18
Kawamura, K., Higuchi, T., & Fujiwara, S. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00047-21 · Cited by 17
Alternate deacylating specificities of the archaeal sirtuins Sir2Af1 and Sir2Af2
Ringel, A. E., Roman, C., & Wolberger, C. (2014) · Protein Science · doi:10.1002/pro.2546 · Cited by 18
Age-dependent clinical prognostic value of histone modifications in colorectal cancer
Goossens-Beumer, I. J., Benard, A., van Hoesel, A. Q., Zeestraten, E. C. M., Putter, H., Böhringer, S., Liefers, G., Morreau, H., van de Velde, C. J. �., & Kuppen, P. J. K. (2014) · Translational research · doi:10.1016/j.trsl.2014.11.001 · Cited by 18
Saha, B., Lessel, D., Nampoothiri, S., Rao, A. S., Hisama, F. M., Peter, D. C. V., Bennett, C., Nürnberg, G., Nürnberg, P., Martin, G. M., et al. (2013) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1 · Cited by 19
Post-translational modifications of nuclear sirtuins
Zhao, K., & Zhou, Z. (2019) · Genome Instability & Disease · doi:10.1007/s42764-019-00001-x · Cited by 19
Wang, D., Li, C. L., & Zhang, X. (2014) · DNA and Cell Biology · doi:10.1089/dna.2013.2257 · Cited by 17
Lee, Y. L., Lin, S., Hou, K., Kok, S., Lai, E. H., Wang, H. ‐., Chang, J. Z., Yang, H., & Hong, C. (2016) · International Endodontic Journal · doi:10.1111/iej.12742 · Cited by 17
Nutritional biomarkers: Current view and future perspectives
Pande, S., Kratasyuk, V. A., Медведева, Н. Н., Kolenchukova, O. A., & Salmina, A. B. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1350136 · Cited by 18
Killoy, K. M., Pehar, M., Harlan, B. A., & Vargas, M. R. (2021) · The FASEB Journal · doi:10.1096/fj.202000386rr · Cited by 17
Jia, B., Chen, J., Wang, Q. L., Sun, X., Han, J., Guastaldi, F. P. S., Xiang, S., Ye, Q., & He, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.648627 · Cited by 17
Cysteine‐Assisted Click‐Chemistry for Proximity‐Driven, Site‐Specific Acetylation of Histones
Afonso, C. F., Marques, M. C., António, J. P. M., CORDEIRO, C. A., Góis, P. M. P., Cal, P. M. S. D., & Bernardes, G. J. L. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202208543 · Cited by 16
Zhao, K., Zheng, M., Su, Z., Ghosh, S., Zhang, C., Zhong, W., Ho, J. W. K., Jin, G., & Zhou, Z. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112939 · Cited by 16
Lalioti, V. S., Vergarajauregui, S., Villasanté, A., Pulido, D., & Sandoval, I. V. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24355 · Cited by 16
Esnault, G., Majocchi, S., Martinet, D., Schmutz, N. B., Beckmann, J. S., & Mermod, N. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00779-08 · Cited by 19
Changes in human sirtuin 6 gene promoter methylation during aging
Sahin, K., Yılmaz, S., & Gözükırmızı, N. (2014) · Biomedical Reports · doi:10.3892/br.2014.266 · Cited by 16
Avrahami, E. M., Levi, S., Zajfman, E., Regev, C., Ben‐David, O., & Arbely, E. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00314 · Cited by 15
miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6.
Ruan, L., Chen, J., Ruan, L., Tan, A., & Wang, P. (2018) · PubMed Central · Cited by 16
Sirtuin 6 and metabolic genes interplay in Warburg effect in cancers
Al‐Azzam, N. Z. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-110 · Cited by 16
HAT/HDAC: The epigenetic regulators of inflammatory gene expression (Review)
Swaroop, S., Batabyal, A., & Bhattacharjee, A. (2021) · International Journal of Epigenetics · doi:10.3892/ije.2021.5 · Cited by 12
SIRT6 serves as a polyhedron in glycolytic metabolism and ageing-related diseases
Yuan, Z., Zeng, Y., Tian, Y., Wang, S., Hong, B., & Yang, M. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111765 · Cited by 14
SIRT6 deficiency causes ovarian hypoplasia by affecting Plod1 ‐related collagen formation
Li, L., Hua, R., Hu, K., Chen, H., Yin, Y., Shi, X., Peng, K., Huang, Q., Qiu, Y., Li, X., et al. (2023) · Aging Cell · doi:10.1111/acel.14031 · Cited by 15
Chang, D., Shi, G., Durand‐Dubief, M., Ekwall, K., & Lu, A.-L. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.11.037 · Cited by 15
Alternative Lengthening of Telomeres and Chromatin Status
Udroiu, I., & Sgura, A. (2019) · Genes · doi:10.3390/genes11010045 · Cited by 15
Metadata
- Authors
- Michishita, E., McCord, R. A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T. L. A., Barrett, J. C., Chang, H. Y., Bohr, V. A., Ried, T., Gozani, O., & Chua, K. F.
- Affiliations
- Stanford Medicine (US)
- VA Palo Alto Health Care System (US)
- Department of Biological Sciences (RU)
- National Institutes of Health (US)
- Corresponding author
- Chua, Katrin F.
- ORCID
- Venue
- Nature
- Published
- 2008-03
- Volume
- 452
- Issue
- 7186
- Pages
- 492-496
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2646112
- OpenAlex
- W2029969982
- Semantic Scholar
- e93e298451cb0d965e8933da9a3ab04e44f65ff0
- Cited by
- 1,111
- References
- 32
- Citations by year
- 2026: 35 · 2025: 35 · 2024: 45 · 2023: 59 · 2022: 57 · 2021: 68 · 2020: 75 · 2019: 64 · 2018: 75 · 2017: 63 · 2016: 83 · 2015: 68 · 2014: 62 · 2013: 94 · 2012: 57
- FWCI
- 23.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging (R01AG028867, K08AG028961)
- National Institute of General Medical Sciences (R01GM079641)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- SIRT6, telomeric chromatin, telomere maintenance, premature aging, Werner syndrome, WRN, cellular senescence, chromatin silencing, telomere dysfunction, NAD+-dependent deacetylation
- MeSH terms
- Werner Syndrome Helicase, Acetylation, Cell Line, Chromatin, DNA Replication, Exodeoxyribonucleases, Fibroblasts, Histone Deacetylases, Histones, Humans, Lysine, Phenotype, Protein Binding, Werner Syndrome, Telomere, Cellular Senescence, Telomerase, Sirtuins, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
